Literature DB >> 9667062

Psychological features of acromegaly.

K Furman1, S Ezzat.   

Abstract

Acromegaly is a serious but often undiagnosed condition that is often unrecognized for many years. The delay from onset of symptoms until the time of diagnosis results in a unique constellation of physical and mental problems for patients and health care professionals. The purpose of this chapter is to identify the psychological consequences experienced by individuals affected with pituitary tumors which alter growth hormone release. As little research has been completed on the subject, very little is known, or has been applied, in the treatment of these patients. To identify the presence of psychological features, the research which exists and an in-depth qualitative analysis of the personal experience of one of the author (K.F.), having suffered a pituitary macroadenoma with accompanying acromegaly, is described. Our findings are compared with those from an earlier series and the few published reports.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667062     DOI: 10.1159/000012275

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  10 in total

1.  Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.

Authors:  T Psaras; M Milian; V Hattermann; B E Will; M Tatagiba; J Honegger
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

2.  Stigma and unhealthy psychological characteristics in patients with acromegaly: A cross-sectional study and identification of the associated factors.

Authors:  Yanqing Li; Xiaomei Zhang; Jiajia Zhang; Dandan Zhang; Ya Wang; Yingqian Zhu; Xiuqun Xu
Journal:  Acta Neurochir (Wien)       Date:  2022-05-21       Impact factor: 2.816

3.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

4.  Quality of life in female patients with acromegaly.

Authors:  O Celik; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

Review 5.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

6.  Body Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls.

Authors:  Helen M Conaglen; Dennis de Jong; Veronica Crawford; Marianne S Elston; John V Conaglen
Journal:  Int J Endocrinol       Date:  2015-05-20       Impact factor: 3.257

Review 7.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

8.  Acromegaly Quality of Life Questionnaire (AcroQoL).

Authors:  Xavier Badia; Susan M Webb; Luis Prieto; Nuria Lara
Journal:  Health Qual Life Outcomes       Date:  2004-02-27       Impact factor: 3.186

9.  Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.

Authors:  Sonia Cheng; Rany Al-Agha; Paula B Araujo; Omar Serri; Sylvia L Asa; Shereen Ezzat
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues.

Authors:  Cecilia Follin; Sven Karlsson
Journal:  Endocr Connect       Date:  2016-07-25       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.